In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022
The Asia Pacific (APAC) region is a fast-growing in vitro diagnostics (IVD) market, which is witnessing increasing focus by leading global players in the market. Southeast Asia has been identified as one of the key regions in APAC region offering significant opportunities for IVD companies.
This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia, and Singapore. These three countries together represent a fast-growing geographic region offering significant opportunity for IVD companies. The total population of these three countries is over 310 million, which is close to the population in the United States.
Among these three countries, Singapore has established world class healthcare service capabilities in terms of infrastructure as well as skilled manpower. Though the population is less than 6 million, the Singapore market is attractive for IVD companies and it has become a medical tourism hub in the region. Indonesia, on the other hand, is a country with a huge population of about 275 million people. The country is taking significant steps to improve its healthcare infrastructure, which is offering considerable opportunities for IVD companies. The Malaysian market, with a population of about 32 million falls in between these two countries, both in terms of healthcare service capabilities and growth potentials.
In Vitro Diagnostics (IVD) in Malaysia, Singapore, and Indonesia, 2022 covers the following segments:
- POC
- Clinical Chemistry
- Immunoassays
- Molecular Assays
- Hematology
- Coagulation
- Microbiology and Virology
- Blood Testing and Typing
- Histology and Cytology
- Abbott Diagnostics
- ARKRAY
- Beckman Coulter, Inc. / Danaher
- Becton, Dickinson, and Company (BD)
- BioCytech Corporation
- bioMérieux Inc.
- Bio-Rad Laboratories, Inc.
- Caris Life Sciences
- Cephei
- CTK Biotech Inc
- Danaher Corporation
- Dexcom
- DiaSorin S.p.A
- Grifols S.A.
- Healgen Scientific LLC
- Hologic, Inc.
- Horiba Medical
- Lucence Diagnostics
- Medical Innovation Ventures Sdn. Bhd. (Mediven)
- Mindray (Shenzhen Mindray Bio-medical Electronics Co., Ltd.)
- MiRXES Pte Ltd.
- OraSure Technologies, Inc.
- Ortho Clinical Diagnostics (Ortho)
- PerkinElmer, Inc. (PE)
- QIAGEN
- Reszon Diagnostics International
- Roche Diagnostics
- Sysmex Corporation
- Vela Diagnostics
- Veredus Laboratories Pte Ltd
- Executive Summary
- Malaysia: Healthcare and Regulatory Landscape
- Regulation of Medical devices in Malaysia
- IVD Market Size Estimation and Forecast for Malaysia
- Table Malaysia’s IVD Market, by Segment (POC, Clinical Chemistry, Immunoassays, Molecular Assays, Hematology, Coagulation, Microbiology and Virology, Blood Testing and Typing, &Histology and Cytology), 2022-2027 ($ Millions)
- Indonesia: Healthcare and Regulatory Landscape
- Market Drivers and Challenges
- The Health Insurance System
- Table Indonesia’s Medical Device Demand, Local Production, Exports, and Imports, 2018-2021, ($ Billions)
- Policies on Procurement, Import, Market Authorization, and Halal Certification of IVDs
- IVD Market Size Estimation and Forecast for Indonesia
- Table Indonesia’s IVD Market, by Segment (POC, Clinical Chemistry, Immunoassays, Molecular Assays, Hematology, Coagulation, Microbiology and Virology, Blood Testing and Typing, &Histology and Cytology), 2022-2027 ($ Millions)
- Singapore: Healthcare and Regulatory Landscape
- The Health Insurance System
- Policies on Import, Registration, and Distribution of IVDs in Singapore
- Recovery of the Medical Tourism Sector
- IVD Market Size Estimation and Forecast for Singapore
- Table Indonesia’s IVD Market, by Segment (POC, Clinical Chemistry, Immunoassays, Molecular Assays, Hematology, Coagulation, Microbiology and Virology, Blood Testing and Typing, &Histology and Cytology), 2022-2027 ($ Millions)
- The Combined IVD Markets of Malaysia, Indonesia, and Singapore
- Table Total IVD Market Size in Malaysia, Indonesia, and Singapore and Forecasts, 2022-2027 ($ Millions)
- Table Market Shares of the Leading IVD Companies (Roche, Abbott, Siemens Healthineers, Beckman Coulter, bioMérieux, Bio-Rad, Sysmex, and Others) in Malaysia, Indonesia, and Singapore, 2022
- Malaysia: Healthcare and Regulatory Landscape
- COVID-19 Testing Market Trends
- COVID-19 Testing Trends in Malaysia (2020-2022)
- Table COVID-19 Self-Tests Approved in Malaysia (As of February 2022)
- Table Covid-19 Testing Markets (Molecular Assays, Immunoassays, and POC Tests) in Malaysia, 2022- 2027 ($ Millions)
- Table COVID-19 Testing Types (Immunoassay Lab-based, Molecular Diagnostics Lab-based, and Rapid- POC) and their Shares in Malaysia, 2022, ($ Millions)
- COVID-19 Testing Trends in Indonesia (2020-2022)
- Table Covid-19 Testing Markets (Molecular Assays, Immunoassays, and POC Tests) in Indonesia, 2022- 2027 ($ Millions)
- Table COVID-19 Testing Market Segments (Immunoassay Lab-based, Molecular Diagnostics Labbased, and Rapid-POC) and their Shares in Indonesia, 2022, ($ Millions)
- COVID-19 Testing Trends in Singapore (2020-2022)
- Table Covid-19 Testing Markets (Molecular Assays, Immunoassays, and POC Tests) in Singapore, 2022- 2027 ($ Millions)
- Table COVID-19 Testing Market Segments (Immunoassay Lab-based, Molecular Diagnostics Labbased, and Rapid-POC) and their Shares in Singapore, 2022 ($ Millions)
- Table COVID-19 Testing Market Segments (Immunoassay Lab-based, Molecular Diagnostics Labbased, and Rapid-POC) and their Combined Shares in Malaysia, Indonesia, and Singapore, 2022 ($ Millions)
- Table COVID-19 Testing Markets in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)
- COVID-19 Testing Trends in Malaysia (2020-2022)
- Point-of-Care Tests
- Pregnancy and Fertility Testing
- Cancer Testing
- Lipid Testing
- Drug of Abuse (DOA) Testing
- Infectious Disease Testing
- HIV
- Hepatitis
- Table Prevalence of Co-infection of HIV with HBV and HCV in Malaysia, Indonesia, and Singapore
- Tuberculosis (TB)
- Tropical Diseases
- Table Selected List of Companies Offering POC Tests for Tropical Diseases in Malaysia, Indonesia, and Singapore
- Respiratory Diseases
- Sexual Health
- Diabetes Testing – Blood Glucose Monitoring
- Other POC tests
- Table POC Test Sales by Category (Fertility/ Pregnancy, Covid-19, Other Infectious diseases, Glucose (self), Glucose Continuous, Glucose Professional, HbA1c POC, Fecal Occult Blood Critical care POC, Coagulation, Cardiac Markers, Hematology, Drug of Abuse, Cholesterol, and Other), Malaysia, 2022-2027 ($ Millions)
- Table POC Test Sales by Category (Fertility/ Pregnancy, Covid-19, Other Infectious diseases, Glucose (self), Glucose Continuous, Glucose Professional, HbA1c POC, Fecal Occult Blood Critical care POC, Coagulation, Cardiac Markers, Hematology, Drug of Abuse, Cholesterol, and Other), Indonesia, 2022-2027 ($ Millions)
- Table POC Test Sales by Category (Fertility/ Pregnancy, Covid-19, Other Infectious diseases, Glucose (self), Glucose Continuous, Glucose Professional, HbA1c POC, Fecal Occult Blood Critical care POC, Coagulation, Cardiac Markers, Hematology, Drug of Abuse, Cholesterol, and Other), Singapore, 2022-2027 ($ Millions)
- Table POC Test Sales in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)
- Table Estimation of Market Shares of the Leading Companies (Abbott, Roche, and Siemens Healthineers) in the POC Testing Markets in Malaysia, Indonesia, and Singapore, 2022
- Core Lab and Clinical Chemistry
- Workstation Consolidation and Laboratory Automation
- Core Lab: Market Analysis
- Table Core Lab Automation Solutions Used by a Selected List of Hospitals (MOH Hospitals [General Hospitals], MOH [District Hospitals], University Hospitals, and Private Hospitals) in Malaysia
- Table Core Lab Solution Sales in Malaysia, Indonesia, and Singapore; 2022-2027 ($ Millions)
- Table Leading Companies (Roche, Abbott, Siemens, Healthineers, Beckman Coulter, and Other) in the Core Lab Solutions Markets in Malaysia, Indonesia, and Singapore, 2022
- Clinical Chemistry Market Analysis
- Blood Gases and Electrolytes
- Urinalysis
- Table Clinical Chemistry Sales by Test Category (General Chemistry, Blood Gases, and Urinalysis), Malaysia, 2022-2027 ($ Millions)
- Table Clinical Chemistry Sales by Test Category (General Chemistry, Blood Gases, and Urinalysis), Indonesia, 2022-2027 ($ Millions)
- Table Clinical Chemistry Sales by Test Category (General Chemistry, Blood Gases, and Urinalysis), Singapore, 2022-2027 ($ Millions)
- Immunoassays
- Cardiac Markers
- Tumor Markers
- Diabetes
- Thyroid
- Autoimmune Diseases
- Other Immunoassay Segments
- Table Immunoassay (Non-Infectious Diseases) Sales by Category (Diabetes, Tumor Markers, Thyroid, Proteins, Cardiac Markers, and Other), Malaysia, 2022-2027 ($ Millions)
- Table Immunoassay (Non-Infectious Diseases) Sales by Category (Diabetes, Tumor Markers, Thyroid, Proteins, Cardiac Markers, and Other), Indonesia, 2022-2027 ($ Millions)
- Table Immunoassay (Non-Infectious Diseases) Sales by Category (Diabetes, Tumor Markers, Thyroid, Proteins, Cardiac Markers, and Other), Singapore, 2022-2027 ($ Millions)
- Table Immunoassay (Non-Infectious Diseases) Sales in Malaysia, Indonesia, and Singapore; 2022-2027 ($ Millions)
- Table Leading Companies (Roche, Abbott, Siemens Healthineers, and Others) in the Immunoassays (Non-Infectious Diseases) Markets in Malaysia, Indonesia, and Singapore, 2022
- Molecular Assays
- Oncology
- Table Selected List of NGS-based Cancer Tests Approved for Clinical Use in Singapore
- Table NGS-based Cancer Testing in Singapore: Key Challenges
- Genetic Diseases and Disorders
- Prenatal Testing, Pre-Implantation Genetic Testing, etc.
- Transplant Diagnostics
- Table Molecular Diagnostics (Non-Infectious Diseases) Sales* by Category (Oncology Assays, Genetic Diseases, and Transplant Testing), Malaysia, 2022-2027 ($ Millions)
- Table Molecular Diagnostics (Non-Infectious Diseases) Sales* by Category (Oncology Assays, Genetic Diseases, and Transplant Testing), Indonesia, 2022-2027 ($ Millions)
- Table Molecular Diagnostics (Non-Infectious Diseases) Sales* by Category (Oncology Assays, Genetic Diseases, and Transplant Testing), Singapore, 2022-2027 ($ Millions)
- Table Molecular Diagnostics (Non-Infectious Diseases) Sales* in Malaysia, Indonesia, and Singapore; 2022-2027 ($ Millions)
- Table Leading Companies (Roche, Abbott, QIAGEN, and Others) in the Molecular Diagnostics (Non- Infectious Diseases) Markets in Malaysia, Indonesia, and Singapore, 2022
- Oncology
- Hematology
- Laboratory-based Hematology: Technology and Market Trends
- Table Laboratory-based Hematology Sales in Malaysia, Indonesia, and Singapore; 2022-2027 ($ Millions)
- Table Leading Companies (Sysmex, Beckman Coulter/Danaher, Mindray, Roche, and Others) in the Laboratory-based Hematology Markets in Malaysia, Indonesia, and Singapore, 2022
- Laboratory-based Hematology: Technology and Market Trends
- Coagulation
- Impact of COVID-19
- Lab-based Coagulation Testing
- Table Lab-based Coagulation Test Sales, Malaysia, 2022-2027 ($ Millions)
- Table Lab-based Coagulation Test Sales, Indonesia, 2022-2027 ($ Millions)
- Table Lab-based Coagulation Test Sales, Singapore, 2022-2027 ($ Millions)
- Table Lab-based Coagulation Test Sales in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)
- Table Estimation of Market Shares of the Leading Companies in the Lab-based Coagulation Testing Markets in Malaysia, Indonesia, and Singapore, 2022
- Microbiology and Virology
- Antibiotic Resistant Infections: Challenges and Solutions
- Syndromic Testing
- Diagnosis of Prevalent Infectious Diseases in Malaysia, Indonesia, and Singapore
- Hepatitis Testing
- Table Selected List of Commercial Clinical Microbiology Immunoassays and Molecular Assays for Hepatitis in Malaysia, Indonesia, and Singapore
- Sepsis and Hospital Acquired Infections (HAI) Testing
- HIV Testing
- Table Selected List of Commercial Clinical Microbiology Immunoassays and Molecular Assays for HIV in Malaysia, Indonesia, and Singapore
- Sexually Transmitted Diseases (STDs) Testing
- Table Selected List of Commercial Clinical Microbiology Immunoassays and Molecular Assays for STDs* in Malaysia, Indonesia, and Singapore
- ToRCH
- Respiratory Infection Testing
- Hepatitis Testing
- Clinical Microbiology and Virology Market Segments
- Tuberculosis (TB) Testing
- Other Prevalent Infectious Diseases and their Diagnosis in Malaysia, Indonesia, and Singapore
- ID/AST: Market Analysis
- ID/AST Systems: Panels, Auto, and Supplies
- Table ID/AST Systems Market Distribution by Product Type (Panels, Supplies, and Auto) in Malaysia, Indonesia, and Singapore
- Blood Culture
- Chromogenic Media
- Rapid Tests Performed on Colonies from Culture Media
- Table Microbiology ID/AST Markets in Malaysia, 2022-2027 ($ Millions)
- Table Microbiology ID/AST Markets in Indonesia, 2022-2027 ($ Millions)
- Table Microbiology ID/AST Markets in Singapore, 2022-2027 ($ Millions)
- Table ID/AST Markets in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)
- ID/AST Systems: Panels, Auto, and Supplies
- Microbiology Immunoassays
- Table Laboratory-based Microbiology Immunoassays Markets in Malaysia, 2022-2027 ($ Millions)
- Table Market Shares of the Leading Companies in the Lab-based Microbiology Immunoassay Markets in Malaysia, 2022
- Table Laboratory-based Microbiology Immunoassays Markets in Indonesia, 2022-2027 ($ Millions)
- Table Market Shares of the Leading Companies in the Lab-based Microbiology Immunoassay Markets in Indonesia, 2022
- Table Laboratory-based Microbiology Immunoassays Markets in Singapore, 2022-2027 ($ Millions)
- Table Market Shares of the Leading Companies in the Lab-based Microbiology Immunoassay Markets in Singapore, 2022
- Table Combined Clinical Laboratory-Based Microbiology Immunoassay Market by Pathogen in Malaysia, Indonesia, and Singapore, 2022 ($ millions)
- Table Microbiology Immunoassays (Lab-based) Markets in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)
- Molecular Microbiology (Laboratory-based)
- Table Laboratory-based Molecular Microbiology Markets in Malaysia, 2022-2027 ($ Millions)
- Table Laboratory-based Molecular Microbiology Markets in Indonesia, 2022-2027 ($ Millions)
- Table Laboratory-based Molecular Microbiology Markets in Singapore, 2022-2027 ($ Millions)
- Table Combined Clinical Molecular Microbiology Market by Pathogen in Malaysia, Indonesia, and Singapore, 2022 ($ millions)
- Table Microbiology Molecular Diagnostics Markets in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)
- Table Microbiology and Virology Markets in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)
- Blood Banking Services
- Blood Typing and Grouping
- Blood Testing
- Market Trends Triggered by COVID-19 Pandemic
- Blood Banking Service Markets in Malaysia
- Table Blood Testing and Typing Market by Category, Malaysia, 2022-2027 ($ Millions)
- Table Market Shares of the Leading Companies in the Blood Testing and Typing Markets in Malaysia, 2022
- Blood Banking Service Markets in Indonesia
- Table Distribution of Blood Centers (BCs) in Indonesia, by Province
- Table Blood Testing and Typing Market by Category, Indonesia, 2022-2027 ($ Millions)
- Table Market Shares of the Leading Companies in the Blood Testing and Typing Markets in Indonesia, 2022
- Blood Banking Service Markets in Singapore
- Table Blood Testing and Typing Market by Category, Singapore, 2022-2027 ($ Millions)
- Table Blood Testing and Typing Markets in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)
- Blood Typing and Grouping
- Histology and Cytology
- HPV Testing: A Fast-Growing Market Segment
- Technological Advancements in Histology and Cytology
- Market Trends
- Table Cervical Cancer Incidences in Singapore, Malaysia, and Indonesia, 2020
- Table Cervical Cancer Deaths in Singapore, Malaysia, and Indonesia, 2020
- Table Leading Vendors Offering Cervical Cancer Screening Products in Malaysia, Indonesia, and Singapore
- Histology and Cytology Markets in Malaysia
- Digital Pathology Solutions in Malaysia
- Table The Histology and Cytology IVD Markets in Malaysia, by Type: 2022 -2027
- Digital Pathology Solutions in Malaysia
- Histology and Cytology Markets in Indonesia
- Digital Pathology Solutions in Indonesia
- Table The Histology and Cytology IVD Markets in Indonesia, by Type: 2022 –2027
- Digital Pathology Solutions in Indonesia
- Histology and Cytology Markets in Singapore
- Digitization of Histology Laboratories in Singapore
- Table Histology and Cytology Markets in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)
- Table Market Shares of the Leading Companies in the Histology and Cytology Markets in Malaysia, Indonesia, and Singapore, 2022
- Digitization of Histology Laboratories in Singapore
- Company Profiles
- The Top Tier IVD Companies in Malaysia, Indonesia, and Singapore
- Abbott Diagnostics
- Beckman Coulter, Inc. / Danaher
- Becton, Dickinson, and Company (BD)
- bioMérieux Inc.
- Bio-Rad Laboratories, Inc.
- Cepheid / Danaher
- Danaher Corporation
- DiaSorin S.p.A
- Grifols S.A.
- Hologic, Inc.
- Ortho Clinical Diagnostics (Ortho)
- PerkinElmer, Inc. (PE)
- QIAGEN
- Roche Diagnostics
- Siemens Healthineers
- Sysmex Corporation
- Company Profiles: The Second Tier - Multinationals, Regional Companies, etc.
- ARKRAY
- BioCytech Corporation
- Caris Life Sciences
- CTK Biotech Inc
- Dexcom
- Healgen Scientific LLC
- Horiba Medical
- Lucence Diagnostics
- Medical Innovation Ventures Sdn. Bhd. (Mediven)
- Mindray (Shenzhen Mindray Bio-medical Electronics Co., Ltd.)
- MiRXES Pte Ltd.
- OraSure Technologies, Inc.
- Reszon Diagnostics International
- Vela Diagnostics
- Veredus Laboratories Pte Ltd
- IVD Distributors in Malaysia, Indonesia, and Singapore
- Table Selected List of IVD Distributors in Malaysia
- Table Selected List of IVD Distributors in Indonesia
- Table Selected List of IVD Distributors in Singapore
- The Top Tier IVD Companies in Malaysia, Indonesia, and Singapore
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook